New drug shows hope for Hodgkin lymphoma patients

Scientists tested a new drug for adults with hard-to-treat Hodgkin lymphoma, and found that if it was given immediately after a stem cell transplant, it makes the patients survive without the disease progressing for twice as long as those given placebo helped them. The findings of a phase 3 trial of brentuximab vedotin , the first new drug for Hodgkin lymphoma in over 30 years, are potentially practice changing for this young cancer population who have exhausted other treatment options and for whom prognosis is poor.

http://ift.tt/1EutGq0